european psychiatric association


Section committee

GAEBEL Wolfgang, Co-Chair
MUCCI Armida, Secretary

Section mission

This Section's mission is to:

The EPA section “Schizophrenia” is aimed to promote high standards in research, training and clinical practice in its field of interest and to fight the stigma related to the diagnosis of schizophrenia.

Section objectives

  1. To disseminate updated knowledge relevant to etiopathogenesis, prevention, diagnosis and treatment of schizophrenia
  2. To favour cultural exchanges and cross-fertilization among different approaches to the study of this complex diagnostic entity
  3. To promote early diagnosis and identification of at risk subjects
  4. To raise standards of care
  5. To address ethical issues in research and clinical care involving people with schizophrenia
  6. To identify unmet needs and means to address them
  7. To develop and deliver training courses for undergraduate, postgraduate and continuing professional development
  8. To compare clinical service, training, research and policy across Europe

Annual reports

Future Activities


EPA Guidance on Treatment of Negative Symptoms
EPA Guidance  on Treatment of Negative Symptoms
30 April 2021
Journal :
European Psychiatry, accepted for publication
Authors :
S. Galderisi, S. Kaiser, I. Bitter, M. Nordentoft, A. Mucci, M. Sabé, G. M. Giordano, M. Ø. Nielsen, L. B. Glenthøj, P. Pezzella, P. Falkai, S. Dollfus, W. Gaebel
Acknowledged as official Section publication?